Chugai Pharmaceutical Valuation
| CHGCF Stock | USD 33.27 0.00 0.00% |
At this time, the firm appears to be undervalued. Chugai Pharmaceutical shows a prevailing Real Value of $35.88 per share. The current price of the firm is $33.27. Our model approximates the value of Chugai Pharmaceutical from analyzing the firm fundamentals such as Current Valuation of 39.67 B, profit margin of 0.30 %, and Return On Equity of 0.29 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Undervalued
Today
Please note that Chugai Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Chugai Pharmaceutical is based on 3 months time horizon. Increasing Chugai Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Chugai Pharmaceutical Co is useful when determining the fair value of the Chugai pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Chugai Pharmaceutical. Since Chugai Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chugai Pink Sheet. However, Chugai Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 33.27 | Real 35.88 | Hype 33.27 |
The real value of Chugai Pink Sheet, also known as its intrinsic value, is the underlying worth of Chugai Pharmaceutical Company, which is reflected in its stock price. It is based on Chugai Pharmaceutical's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Chugai Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Chugai Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Chugai Pharmaceutical Co helps investors to forecast how Chugai pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chugai Pharmaceutical more accurately as focusing exclusively on Chugai Pharmaceutical's fundamentals will not take into account other important factors: Chugai Pharmaceutical Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Chugai Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Chugai Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chugai Pharmaceutical competition to find correlations between indicators driving Chugai Pharmaceutical's intrinsic value. More Info.Chugai Pharmaceutical Co is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about 0.20 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Chugai Pharmaceutical Co is roughly 4.93 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Chugai Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chugai Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chugai Pharmaceutical's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chugai Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chugai Pharmaceutical and how it compares across the competition.
About Chugai Pharmaceutical Valuation
The pink sheet valuation mechanism determines the current worth of Chugai Pharmaceutical Co on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Chugai Pharmaceutical Co. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Chugai Pharmaceutical based exclusively on its fundamental and basic technical indicators. By analyzing Chugai Pharmaceutical's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Chugai Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chugai Pharmaceutical. We calculate exposure to Chugai Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chugai Pharmaceutical's related companies.Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.
8 Steps to conduct Chugai Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Chugai Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Chugai Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Chugai Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Chugai Pharmaceutical's revenue streams: Identify Chugai Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Chugai Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Chugai Pharmaceutical's growth potential: Evaluate Chugai Pharmaceutical's management, business model, and growth potential.
- Determine Chugai Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Chugai Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Chugai Pharmaceutical represents a small ownership stake in the entity. As a stockholder of Chugai, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Chugai Pharmaceutical Dividends Analysis For Valuation
Please note that Chugai Pharmaceutical has scaled down on payment of dividends at this time.
There are various types of dividends Chugai Pharmaceutical can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Chugai shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Chugai Pharmaceutical Co directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Chugai pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Chugai Pharmaceutical by the value of the dividends paid out.
Chugai Pharmaceutical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Chugai Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.6 B | |
| Quarterly Earnings Growth Y O Y | 0.036 | |
| Forward Price Earnings | 15.4321 | |
| Retained Earnings | 1.1 T |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chugai Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Chugai Pink Sheet analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |